Navigation Links
Novus International to Present Scientific Findings on Prebiotics during Aquaculture Europe 2013
Date:8/6/2013

ST. LOUIS, Aug. 6, 2013 /PRNewswire/ -- Aquaculture Europe 2013 will take place in Trondheim, Norway on August 9th and Novus will be present to support this important international industry conference. The theme of this year's event, Making Sense of Science, implies setting priorities for knowledge generation.

(Logo: http://photos.prnewswire.com/prnh/20130806/CG59070LOGO)

"Novus is firmly committed to supporting the aquaculture industry, which continues to experience tremendous growth," notes Dr. Francisco Gomes, Executive Manager, Novus Aqua. "Novus embraces every opportunity it has to share the scientific research and information that is the foundation for the development of products and solutions that maximize efficiency and profitability at every stage in the aquaculture production chain."

Knowledge sharing is a key aspect of the organizational culture at Novus. "We're continually focusing on the needs of the animal and the understanding of our customer's value chain," noted Dr. Gomes. "We have invested extensive resources in the European marine fish industry. Through strategic partnerships with customers and research partners we have been able to achieve significant milestones in issues such as sea lice myxosporidia and enteritis."

Craig Browdy, Novus Executive Manager, Aquaculture Research, will be presenting a scientific abstract on Saturday, August 10th beginning at 10:50 a.m. Entitled, Mode of action and practical applications of the prebiotic PREVIDA® to improve fish health, the abstract will discuss the results of a series of in vitro, in vivo and ex vivo field and lab tests with PREVIDA®. In this research PREVIDA binded with bacterial binding receptors, which left them inaccessible to pathogens, encouraged selective fermentation allowing beneficial bacteria to completely exclude pathogens, and caused significant improvements in gut ultrastructure. These benefits resulted in a reduction of enteritis and improvement in performance in sensitive marine species.

PREVIDA® is a single-source material which has a consistent composition and is of 100 percent natural origin with no added chemicals. Introduced by Novus in 2011, this breakthrough prebiotic won the 2012 North American New Product Innovation Award for Prebiotics. PREVIDA is part of Novus Aqua Health Through Nutrition Solutions.  Our complete portfolio of gut environment modifiers together with our expertise have positioned our technologies as successful tools across the world and the industry.

To learn more about the comprehensive programs and products Novus has available to support the production efficiency and profitability of the aquaculture industry, visit the company's corporate web site at www.novusint.com.

About Novus International, Inc.

Novus International, Inc. is headquartered in metropolitan St. Louis, Missouri, U.S.A. and serves customers in nearly 100 countries around the world. A global leader in developing animal health and nutrition solutions, Novus's products include ALIMET® and MHA® feed supplements, ACTIVATE® nutritional feed acid, ACIDOMIX® preservative premixture, ADVENT® coccidiosis control, CIBENZA® feed additive, MINTREX® chelated trace mineral, SANTOQUIN® feed preservative, MERA™MET aquaculture feed additive, AGRADO® feed antioxidant and many other specialty ingredients. Stratum® Nutrition, a division of Novus Nutrition Brands, LLC, focuses on human nutrition through specialty and functional ingredients for manufacturers of foods, beverages and dietary supplements (www.stratumnutrition.com). Novus is privately owned by Mitsui & Co. (U.S.A.), Inc. and Nippon Soda Co., Ltd. For more information visit www.novusint.com.

®NOVUS, ALIMET, MHA, ACTIVATE, ACIDOMIX, CIBENZA, MAAC, MINTREX, SANTOQUIN and AGRADO are trademarks of Novus International, Inc. and are registered in the United States and other countries. ®ADVENT is a trademark of Viridus Animal Health, LLC, and is registered in the United States and other countries. ®STRATUM NUTRITION is a trademark of Novus Nutrition Brands, LLC, and is registered in the United States and other countries. ®PREVIDA is a registered trademark of TIN, Inc.  ™MERA and SOLUTIONS SERVICE SUSTAINABILITY are trademarks of Novus International, Inc. © 2013 Novus International, Inc. All rights reserved.

CONTACTS: Tracy Barfield
636.794.2411
tracy.barfield@novusint.com

Barbara Hansen
636.926.7436
barbara.hansen@novusint.com


'/>"/>
SOURCE Novus International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Novus International And Verenium Announce Important Progress In The Development Of Novel Enzymes For Animal Health & Nutrition
2. Novus Biologicals Hires David Eansor to Lead New Corporate-Development Effort
3. First Product Candidate Moving Toward Commercialization as Result of Novus International and Verenium Collaboration
4. Mimedx Scientific Study Is Electronically Published in The International Wound Journal
5. GeneCell International, Miami’s Preferred Cord Blood Laboratory, is Pleased to Announce That July is National Cord Blood Awareness Month
6. Join Cornerstone Plastic Surgery for an Exclusive Evening with Internationally Reknowned New York Trained Plastic Surgeon Frederick A. Coville, MD
7. GeneCell International’s Director of Operations, Jose Cirino, Organizes A Series of Educational Seminars with South Florida's Leading Obstetricians and Gynecologist
8. Cellular Dynamics International Announces Launch of Initial Public Offering
9. New Research from SRI International Points to Biomarker that Could Track Huntingtons Disease Progression
10. Rocky Mountain Biologicals Joins International Serum Industry Association
11. Yongye International, Inc. Announces Common Stock Will Resume Trading on the NASDAQ Stock Market on June 17, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... 2016 - New FDA action date of ... FDA action date of July 22, 2016   ... 22, 2016   - Lifitegrast has ... indicated for the treatment of signs and symptoms of dry eye ... potential to be the only product approved in the U.S. in the past decade indicated ...
(Date:2/4/2016)... 4, 2016  CytoSorbents Corporation (NASDAQ: CTSO ... flagship CytoSorb® blood filter to treat deadly inflammation ... world, announced that CEO Dr. Phillip Chan ... Capital Group,s 2016 Disruptive Growth & Healthcare Conference, ... Conference Presentation Details: Where: Convene ...
(Date:2/4/2016)... BEIJING , Feb. 4, 2016 Sinovac ... ), a leading provider of biopharmaceutical products in ... committee of its board of directors received on February ... 3, 2016, from a consortium comprised of PKU V-Ming ... Sinobioway Biomedicine Co., Ltd., CICC Qianhai Development ( ...
(Date:2/3/2016)... 2016  Discovery Laboratories, Inc. (NASDAQ: DSCO ... KL4 surfactant therapies for respiratory diseases, today announced ... inducement award as a component of employment compensation ... President and Chief Executive Officer.  The award was ... 1, 2016 and granted as an inducement material ...
Breaking Biology Technology:
(Date:1/27/2016)... WEST CHESTER, Ohio , Jan. 27, 2016 /PRNewswire/ ... services supplier based in West Chester, Ohio ... and their award winning service staff, based in ... Track,s technical capacity and ability to provide modifications, installations ... John Dovalina , CEO of PLUS, commented, "PLUS ...
(Date:1/21/2016)... --> ... report "Emotion Detection and Recognition Market by Technology (Bio-Sensors, NLP, ... Voice Recognition and Others), Services, Application Areas, End ... published by MarketsandMarkets, the global Emotion Detection and ... Billion by 2020, at a CAGR of 31.9%, ...
(Date:1/15/2016)... Jan. 15, 2016 Recent publicized breaches in ... find new ways to ensure data security and user ... and Android that ties a user,s ... it into a hardware authorization token. Customer service agents ... fingerprint on their KodeKey enabled device to verify their ...
Breaking Biology News(10 mins):